TGFB1 and metabolic dysfunction-associated steatohepatitis: In this study, aberrant gene expression affecting inflammatory signaling pathways (macrophage markers, cytokine, chemokine, interleukin, TGF-β and Wnt-related signaling) was identified in HFHC-associated NASH compared with HF-associated steatosis.